Skip to main content

Table 3 Correlation of biomarkers with therapy response

From: Relevance of circulating nucleosomes and oncological biomarkers for predicting response to transarterial chemoembolization therapy in liver cancer patients

Marker

Time

Response N = 32

No-Response N = 39

P-Value

Nucleosomes (ng/mL)

0 h

107.5

80.7

0.142

 

24 h

81.8

231.1

0.002

 

pc.

-26.2

114.3

< 0.001

AFP (ng/mL)

0 h

4.4

7.9

0.011

 

24 h

4.2

7.9

0.010

 

pc.

0

0

0.822

CYFRA 21-1 (ng/mL)

0 h

1.8

2.0

0.349

 

24 h

2.0

2.2

0.101

 

pc.

0

14.3

0.229

LDH (U/L)

0 h

198.5

200.0

0.288

 

24 h

240.0

250.0

0.746

 

pc.

21.6

21.0

0.712

CRP (mg/dL)

0 h

0.4

0.8

0.424

 

24 h

1.2

1.5

0.361

 

pc.

100.0

133.3

0.644

CHE (kU/L)

0 h

4.4

4.4

0.636

 

24 h

4.6

4.4

0.652

 

pc.

3.0

4.6

0.514

AST (U/L)

0 h

41.5

56.0

0.084

 

24 h

101.0

89.0

0.556

 

pc.

102.6

50.0

0.241

ALT (U/L)

0 h

37.5

38.0

0.652

 

24 h

63.5

57.0

0.138

 

pc.

72.6

19.8

0.051

GLDH (U/L)

0 h

5.0

7.7

0.150

 

24 h

12.7

18.4

0.922

 

pc.

151.7

90.0

0.280

Bilirubin (mg/dL)

0 h

0.9

1.0

0.276

 

24 h

1.5

1.6

0.231

 

pc.

47.7

60.0

0.995

GGT (U/L)

0 h

109.0

192.0

0.034

 

24 h

108.5

206.0

0.027

 

pc.

2.8

5.7

0.234

AP (U/L)

0 h

119.5

140.0

0.023

 

24 h

112.5

143.0

0.006

 

pc.

-4.1

1.9

0.317

  1. Median values and p-values (Wilcoxon-test) are shown for the two response groups (pc. = percental changes)